Recent work in a Ndufs4−/− mouse model of LSS has provided more evidence for the beneficial effects of mTOR inhibition in modulating immune system dysregulation in the pathogenesis of MD [122]. The gene discussed is MTOR; the disease is Leigh syndrome.